Displaying 1 - 20 of 55
April 26, 2018
Who benefits from manufacturer drug rebates? A new report from the Altarum Center for Value in Health Care examines the impact of behind-the-scenes rebates on both health plans and consumers.
A 10-Year Projection of the Prescription Drug Share of National Health Expenditures, Including Nonretail
May 24, 2017
The latest forecast of national health expenditures (NHE) by the Centers for Medicare & Medicaid Services (CMS) has prescription drug spending comprising 10.1% of national health spending in 2015 and increasing to 10.8% in 2025.
May 1, 2017
The purpose of this paper is to compare and contrast BEA's new accounts that estimate health spending by disease category and BLS's Experimental Disease Price Index and to suggest areas for future improvements.
Transcript from the "It Takes YOUR Community" symposium that convened on December 5, 2017. This symposium provides the tools needed to advocate and plan community-based health and long-term services and supports for the coming Age Wave.